CME-CPD Accreditation

56th Congress of the International Society of Paediatric Oncology
17-20 October 2024; Honolulu, USA

Jointly provided by Partners for Advancing Clinical Education (PACE) and The International Society of Paediatric Oncology (SIOP)

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and The International Society of Paediatric Oncology (SIOP).  PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education

PACE designates this live activity for a maximum of 32.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 32.5 contact hours.

Credit Breakdown  

Each participant should claim only those hours of credit that he/she actually spent in the educational activity.

Instructions for Credit

To receive CE credit, please follow these steps:

1. Enter your profile information or create a new account HERE
2. Visit the SIOP 2024 online evaluation HERE
3. Complete the activity evaluation.
4. Upon completion of all evaluation questions, your credit will be made available for download immediately.

For any questions or concerns, please contact us at: education@kenes.com

Target Audience

This activity is intended for pediatric oncology professionals, including doctors, researchers, nurses, and other healthcare providers affiliated with the International Society of Paediatric Oncology (SIOP), with a special focus on young professionals from low and middle-income countries. The congress is a global platform for networking, knowledge-sharing, and collaboration in pediatric oncology, encouraging participation from colleagues across North America, South-East Asia, and Oceania.

Educational Objectives

Upon completion of this activity, participants should be able to:

• Address individual needs in compliance with their Continuous Professional Development (CPD) plan.
• Describe the most recent research-based and clinical developments in pediatric oncology.
• Debate epidemiology, biology, and prognostic factors in children and adolescents with oncologic malignancies.
• Discuss experimental treatments, targeted therapies, and cancer immunology in pediatric cancer.
• Address precision medicine and cancer predisposition in pediatrics.
• Debate novel approaches in radiation therapy, radionics, and imaging modalities in childhood cancer.
• Discuss functional results after surgical resection of pediatric tumors.
• Discuss the prevention and treatment of chemotherapy’s adverse effects.
• Address supportive care and palliative homecare in high- and low-income countries.
• Identify educational resources, networks, and other sources for the exchange of knowledge and learning about pediatric oncology.
• Form new relationships with colleagues with common interests throughout the world.

Faculty and Disclosure of Conflicts of Interest

PACE requires planners, faculty, and others who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Fee Information

Fee information can be found here.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.